Dechra Pharmaceuticals PLC Annual Financial Report (9729K)
07 September 2021 - 6:34PM
UK Regulatory
TIDMDPH
RNS Number : 9729K
Dechra Pharmaceuticals PLC
07 September 2021
7 September 2021
LEI: 213800J4UVB5OWG8VX82
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Availability of 2021 Annual Report and Accounts
The 2021 Annual Report and Accounts is now available to view at
www.dechra.com.
The following documents are scheduled to be mailed to registered
shareholders of the Company on 20 September 2021:
-- 2021 Annual Report and Accounts
-- Notice of the 2021 Annual General Meeting; and
-- Proxy Form for the 2021 Annual General Meeting.
In accordance with Listing Rule 9.6.1 a copy of each of these
documents will be submitted to the National Storage Mechanism and
will be available for viewing shortly after posting.
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: +44 (0) 1606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Our expertise is in the development,
manufacture, marketing and sales of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Trademarks appear throughout this document in italics. Dechra
and the Dechra "D" logo are registered trademarks of Dechra
Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSEAPNXEAEFEEA
(END) Dow Jones Newswires
September 07, 2021 04:34 ET (08:34 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024